Clinical Application of $^{18}F-FDG$ PET in Cervix Cancer

자궁경부암에서 $^{18}F-FDG$ PET의 임상 이용

  • Oh, So-Won (Department of Nuclear Medicine, Seoul National University College of Medicine) ;
  • Kim, Seok-Ki (Department of Nuclear Medicine, National Cancer Center Research Institute and Hospital, National Cancer Center)
  • Published : 2008.12.31

Abstract

Cervix cancer is one of common gynecological cancers in the world, and staged with FIGO or TNM system. However, these clinical staging systems lack information about lymph node or distant metastases, thus imaging modalities are considered to make an appropriate therapeutic plan and enhance overall survival rate. In this context, FDG PET is recommended to pre-treatment stating and prognosis prediction, for it could noninvasively evaluate the status of lymph nodes, especially abdominal paraaortic nodes which are closely related with prognosis. Moreover, the degree of FDG uptake is correlated with prognosis. Although there is no consistent method for surveillance of cervix cancer, FDG PET seems a very important tool in detecting tumor recurrence because it is much more advantageous than conventional imaging modalities such as MRI for discerning recurrent tumor from fibrosis caused by radiation or surgery. Furthermore, FDG PET could be used to evaluate treatment response. On the other hand, recently introduced PET/CT is expected to play an ancillary role to FIGO staging by adding anatomical information, and enhance diagnostic performance of PET by decreasing false positive findings.